BONDI SANDS BROAD SPECTRUM SPF 60 SUNNY DROPS FACE SERUM- avobenzone, homosalate, octisalate, octocrylene solution/ drops

Bondi Sands Broad Spectrum SPF 60 Sunny Drops Face Serum by

Drug Labeling and Warnings

Bondi Sands Broad Spectrum SPF 60 Sunny Drops Face Serum by is a Otc medication manufactured, distributed, or labeled by Baxter Laboratories Pty. Ltd. . Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Active Ingredients Purpose

Avobenzone 3%, Homosalate 12%, Octisalate 5%, Octocrylene 10% Sunscreen

PURPOSE

Uses

• Helps prevent sunburn.
• If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.

KEEP OUT OF REACH OF CHILDREN

• Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

INDICATIONS & USAGE

• Stop use and ask a doctor if rash or irritation occurs.

WARNINGS

Warnings

• For external use only.
• Do not use on damaged or broken skin.
• When using this product keep out of eyes. If eye contact occurs, rinse thoroughly with clean running water.

DOSAGE & ADMINISTRATION

Directions

• Shake well before use.
• Apply liberally and evenly 15 minutes before sun exposure.
• Use a water resistant sunscreen if swimming or sweating.
• Reapply: immediately after towel drying.
  • at least every 2 hours.
• Sun Protection Measures: Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
• Limit time in the sun, especially from 10 a.m.-2 p.m.
• Wear long-sleeved shirts, pants, hats, and sunglasses.
• Children under 6 months: Ask a doctor.

INACTIVE INGREDIENT

Inactive Ingredients

Water/Aqua/Eau, Beeswax, C12-15 Alkyl Benzoate, Silica, Hibiscus Sabdariffa Fruit Extract, PEG-15 Cocamine, Caprylyl Glycol, PEG-40 Stearate, Acrylates/Steareth-20 Methacrylate Copolymer, Caprylhydroxamic Acid, Glycerin, Carbomer, Aminomethyl Propanol, Phenoxyethanol, Sodium Carrageenan, Aloe Barbadensis Leaf Juice, Sodium Chloride, Tocopheryl Acetate.

OTHER SAFETY INFORMATION

Other Information

• Protect the product in this container from excessive heat and direct sun. You may report a serious adverse reaction to 888-339-7642; Monday-Friday, 9 am-5 pm.

PRINCIPAL DISPLAY PANEL

bondi sands

SPF 60 SUNNY DROPS

FACE SERUM

COMPLEXION PROTECTION

FOR CALM, CLEAR SKIN

SUNSCREEN BROAD SPECTRUM SPF 60

1.01 FL. OZ (30mL)

INGREDIENTS AND APPEARANCE

BONDI SANDS BROAD SPECTRUM SPF 60 SUNNY DROPS FACE SERUM 
avobenzone, homosalate, octisalate, octocrylene solution/ drops

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 70157-023
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S)	HOMOSALATE	12 g  in 100 mL
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM)	OCTOCRYLENE	10 g  in 100 mL
AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX)	AVOBENZONE	3 g  in 100 mL
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W)	OCTISALATE	5 g  in 100 mL

Inactive Ingredients
Ingredient Name	Strength
C12-15 ALKYL BENZOATE (UNII: A9EJ3J61HQ)
GLYCERIN (UNII: PDC6A3C0OX)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
PEG-15 COCAMINE (UNII: 8L6LB12TSJ)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
BEESWAX (UNII: 2ZA36H0S2V)
SODIUM CARRAGEENAN (UNII: 7CY8BVL34N)
CAPRYLYL GLYCOL (UNII: 00YIU5438U)
WATER (UNII: 059QF0KO0R)
AMINOMETHYL PROPANOL (UNII: LU49E6626Q)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
ACRYLATES/STEARETH-20 METHACRYLATE COPOLYMER (UNII: EPA1872R1N)
ALOE BARBADENSIS LEAF JUICE (UNII: ZY81Z83H0X)
CAPRYLHYDROXAMIC ACID (UNII: UPY805K99W)
HIBISCUS SABDARIFFA WHOLE (UNII: UH3Z91Y49Y)
PEG-40 STEARATE (UNII: ECU18C66Q7)
CARBOMER (UNII: 0A5MM307FC)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 70157-023-01	30 mL in 1 BOTTLE; Type 0: Not a Combination Product	12/09/2024

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M020	12/09/2024

Labeler - Baxter Laboratories Pty. Ltd.  (740537709)